PRESS RELEASE published on 06/08/2026 at 21:00, 1 month 29 days ago Oxurion launches a software-driven growth strategy with Exagis Oxurion NV announces the software-driven growth strategy launch centered on Exagis, its proprietary clinical research platform. The platform evolves into a broad CDMS commercially serving clinical development market Oxurion NV Exagis Clinical Research Platform Software-driven Growth Strategy CDMS
PRESS RELEASE published on 06/08/2026 at 21:00, 1 month 29 days ago Oxurion lance une stratégie de croissance axée sur le logiciel avec Exagis Oxurion annonce une stratégie de croissance logicielle centrée sur sa plateforme Exagis pour la recherche clinique, visant une évolution vers un écosystème logiciel complet Recherche Clinique Plateforme Logicielle Oxurion Exagis Croissance Logicielle
PRESS RELEASE published on 06/08/2026 at 21:00, 1 month 29 days ago Oxurion lanceert een softwaregedreven groeistrategie met Exagis Oxurion NV kündigt die Einführung einer softwaregesteuerten Wachstumsstrategie für sein klinisches Forschungsplattform Exagis an. Die Plattform wird separat kommerzialisiert, um Softwareeinnahmen zu generieren Wachstumsstrategie Oxurion NV Klinische Forschung Exagis Softwaregesteuert
BRIEF published on 06/03/2026 at 18:05, 2 months 4 days ago Oxurion Announces the Results of its Annual General Meeting Pharmaceutical Investments General Assembly Results Oxurion
BRIEF published on 06/03/2026 at 18:05, 2 months 4 days ago Oxurion Annonce les Résultats de son Assemblée Générale Annuelle Assemblée Générale Investissements Résultats Pharmaceutique Oxurion
BRIEF published on 06/03/2026 at 18:05, 2 months 4 days ago Oxurion Approves Agenda at Annual Shareholders' Meeting Forward-looking Statements Shareholders' Meeting Oxurion NV Leuven Agenda Approval
BRIEF published on 06/03/2026 at 18:05, 2 months 4 days ago Oxurion approuve l'ordre du jour de son assemblée générale annuelle des actionnaires Déclarations Prospectives Assemblée Générale Des Actionnaires Oxurion NV Louvain Approbation De L'ordre Du Jour
PRESS RELEASE published on 06/03/2026 at 18:00, 2 months 4 days ago Oxurion kondigt resultaten aan van de Jaarlijkse Aandeelhoudersvergadering van 1 juni 2026 Oxurion NV houdt succesvolle jaarlijkse aandeelhoudersvergadering waar alle agenda-items zijn goedgekeurd. Meer informatie beschikbaar op de website. Toekomstgerichte verklaringen van kracht Oxurion NV Aandeelhoudersvergadering Europese Farmaceutische Onderaannemers Toekomstgerichte Verklaringen
PRESS RELEASE published on 06/03/2026 at 18:00, 2 months 4 days ago Oxurion Announces Results on the Annual Shareholders' Meeting of 1 June 2026 Oxurion NV (Euronext Brussels: OXUR) successfully held its annual shareholders' meeting in Leuven, with all agenda items approved. Find more about the biopharmaceutical company at oxurion.com Biopharmaceutical Euronext Brussels Annual Shareholders' Meeting Oxurion NV Leuven
BRIEF published on 06/02/2026 at 18:05, 2 months 5 days ago Oxurion étend ses services pour répondre à la demande croissante en matière de recherche clinique sur le GLP-1 Recherche Clinique Oxurion Marché Du GLP-1 Thérapeutiques Peptidiques Services Biométriques
Published on 08/07/2026 at 23:15, 12 hours 41 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 12 hours 56 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 13 hours 26 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 13 hours 41 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/07/2026 at 23:21, 12 hours 35 minutes ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 16 hours 26 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 16 hours 41 minutes ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 17 hours 46 minutes ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:00, 17 hours 56 minutes ago E-PANGO: Composition du capital au 31 juillet 2026
Published on 08/07/2026 at 18:54, 17 hours 2 minutes ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 17 hours 2 minutes ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 17 hours 16 minutes ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 17 hours 16 minutes ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 17 hours 56 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026
